183 related articles for article (PubMed ID: 35189890)
1. An artificial intelligence method to assess the tumor microenvironment with treatment outcomes for gastric cancer patients after gastrectomy.
Chen T; Li X; Mao Q; Wang Y; Li H; Wang C; Shen Y; Guo E; He Q; Tian J; Zhu M; Wu J; Liang W; Liu H; Yu J; Li G
J Transl Med; 2022 Feb; 20(1):100. PubMed ID: 35189890
[TBL] [Abstract][Full Text] [Related]
2. An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts.
Li X; Zhai Z; Ding W; Chen L; Zhao Y; Xiong W; Zhang Y; Lin D; Chen Z; Wang W; Gao Y; Cai S; Yu J; Zhang X; Liu H; Li G; Chen T
Int J Surg; 2022 Sep; 105():106889. PubMed ID: 36084807
[TBL] [Abstract][Full Text] [Related]
3. A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer.
Jiang W; Yu X; Dong X; Long C; Chen D; Cheng J; Yan B; Xu S; Lin Z; Chen G; Zhuo S; Yan J
Front Immunol; 2023; 14():1269700. PubMed ID: 37781377
[TBL] [Abstract][Full Text] [Related]
4. Development and verification of a nomogram for predicting the prognosis of resectable gastric cancer with outlet obstruction.
Wei C; Li C; Chen X; Chen G; Nie R; Zhao C; Zhou Z; Chen Y
BMC Cancer; 2022 Nov; 22(1):1154. PubMed ID: 36348289
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer.
Jiang Y; Wang H; Wu J; Chen C; Yuan Q; Huang W; Li T; Xi S; Hu Y; Zhou Z; Xu Y; Li G; Li R
Ann Oncol; 2020 Jun; 31(6):760-768. PubMed ID: 32240794
[TBL] [Abstract][Full Text] [Related]
6. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
[TBL] [Abstract][Full Text] [Related]
7. Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer.
Zhang D; He W; Wu C; Tan Y; He Y; Xu B; Chen L; Li Q; Jiang J
Front Immunol; 2019; 10():71. PubMed ID: 30761139
[TBL] [Abstract][Full Text] [Related]
8. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
9. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.
Ma M; Xiao H; Li L; Yin X; Zhou H; Quan H; Ouyang Y; Huang G; Li X; Xiao H
World J Surg Oncol; 2019 Dec; 17(1):223. PubMed ID: 31856828
[TBL] [Abstract][Full Text] [Related]
11. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
[TBL] [Abstract][Full Text] [Related]
12. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
13. Age-adjusted Charlson Comorbidity Index (ACCI) is a significant factor for predicting survival after radical gastrectomy in patients with gastric cancer.
Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
BMC Surg; 2019 May; 19(1):53. PubMed ID: 31133008
[TBL] [Abstract][Full Text] [Related]
14. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X
Front Immunol; 2020; 11():621623. PubMed ID: 33613554
[TBL] [Abstract][Full Text] [Related]
15. Radiographical Evaluation of Tumor Immunosuppressive Microenvironment and Treatment Outcomes in Gastric Cancer: A Retrospective, Multicohort Study.
Lin JX; Lin JP; Weng Y; Lv CB; Chen JH; Zhan CY; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zhou WX; Zhang XJ; Zheng CH; Cai LS; Ma YB; Huang CM
Ann Surg Oncol; 2022 Aug; 29(8):5022-5033. PubMed ID: 35294651
[TBL] [Abstract][Full Text] [Related]
16. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.
Lin JX; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
World J Gastroenterol; 2019 Nov; 25(41):6258-6272. PubMed ID: 31749596
[TBL] [Abstract][Full Text] [Related]
17. Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit.
Jiang Y; Xie J; Han Z; Liu W; Xi S; Huang L; Huang W; Lin T; Zhao L; Hu Y; Yu J; Zhang Q; Li T; Cai S; Li G
Clin Cancer Res; 2018 Nov; 24(22):5574-5584. PubMed ID: 30042208
[No Abstract] [Full Text] [Related]
18. Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center.
Kano Y; Ohashi M; Hiki N; Takahari D; Chin K; Yamaguchi K; Tsuda Y; Shoji Y; Yasufuku I; Eto K; Ida S; Kumagai K; Nunobe S; Sano T
Gastric Cancer; 2018 Nov; 21(6):1024-1030. PubMed ID: 29700635
[TBL] [Abstract][Full Text] [Related]
19. Serum ferritin is associated with sarcopenia and predicts long-term survival for gastric cancer undergoing radical gastrectomy.
Zhou D; Zeng C; Zhang L; Gao X; Li G; Wang X
Eur J Gastroenterol Hepatol; 2023 Dec; 35(12):1341-1348. PubMed ID: 37823426
[TBL] [Abstract][Full Text] [Related]
20. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
